Clinical Trials Browser

darinaparsin × Clear all

NCT02653976 2024-01-26

A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Phase 2 Completed

67 enrolled 13 charts

Lymphoma, T-Cell, Peripheral

NCT01435863 2015-08-13

A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)

Phase 1 Completed

Lymphoma, T-Cell, Peripheral

NCT01689220 2014-09-04

A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea

Phase 1 Completed

Lymphoma, T-Cell, Peripheral

NCT00423306 2013-11-14

A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT00423644 2013-11-14

A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b

Phase 2 Unknown

Multiple Myeloma

NCT00509782 2012-08-01

Phase I Trial of ZIO-101 in Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00303199 2012-07-19

Study of ZIO-101 in Multiple Myeloma

Phase 1/2 Completed

Multiple Myeloma

NCT00421213 2012-07-19

Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers

Phase 2 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Bone Marrow Neoplasms, Hematologic Neoplasms

NCT00591396 2012-07-19

A Phase I Trial of ZIO-101 in Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors

NCT00591422 2012-07-19

Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas

Phase 1 Unknown

Neoplasms

NCT00592046 2012-07-19

A Phase I Trial of ZIO-101 in Hematologic Cancers

Phase 1 Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Recurrence, Hematologic Neoplasms

NCT00592163 2012-07-19

Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas

Phase 1 Unknown

Lymphoma, Neoplasms

NCT01139346 2012-07-19

Study of Oral Darinaparsin in Patients With Advanced Solid Tumors

Phase 1 Completed

Carcinoma, Neoplasm Metastasis, Sarcoma

NCT01139359 2012-07-19

Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma

Phase 1 Withdrawn

Lymphoma